Table 2.

Summary of Immunostaining Using EMab-51 and EMab-134

		EMab-51 immunostaining					EMab-134 immunostaining
Tumor type	No. of cases	3+	2+	1+	0	No. of positive cases (%)	3+	2+	1+	0	No. of positive cases (%)
SCC	38	1	2	3	32	6/38 (15.8)	12	13	11	2	36/38 (94.7)
PA	3	0	0	0	3	0/3 (0)	0	0	1	2	1/3 (33.3)
MPA	3	0	0	0	3	0/3 (0)	0	0	2	1	2/3 (66.7)
ACC	2	0	0	0	2	0/2 (0)	0	0	1	1	1/2 (50)
MC	1	0	0	0	1	0/1 (0)	0	0	0	1	0/1 (0)
AL	1	0	0	0	1	0/1 (0)	0	0	1	0	1/1 (100)